Cresset Asset Management »

Akari Therapeutics shares owned by Cresset Asset Management

Quarter-by-quarter ownership of Akari Therapeutics shares owned by Cresset Asset Management from 13F filings

Historical chart of Cresset Asset Management investment in Akari Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics held by Cresset Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics by Cresset Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $106k 21k 5.15

More positions owned by Cresset Asset Management

Arista Networks Com Shs (ANET)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr S&p 100 Etf (OEF)
Alphabet Cap Stk Cl C (GOOG)
Reddit Cl A (RDDT)
Ishares Tr Rus 1000 Grw Etf (IWF)
C H Robinson Worldwide In Com New (CHRW)
Proshares Tr S&p 500 Dv Arist (NOBL)

View all positions for Cresset Asset Management

Top funds holding Akari Therapeutics

Armistice Capital
Cresset Asset Management
IFP Advisors
SBI Securities
Morgan Stanley
Truvestments Capital

View all funds holding Akari Therapeutics